Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity
Cell Metabolism · 2023
DOI: 10.1016/j.cmet.2023.02.006 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cell Metabolism, 2023. Verfasst von Mualla Ozcan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Washington University School of Medicine, St. Louis, MO 63110, USA. Hauptthemen laut MEDLINE: Cardiotoxicity, Heart Failure. Die Arbeit wurde bisher 103-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, BLRD VA.
Abstract (Originalsprache)
Fasting strategies are under active clinical investigation in patients receiving chemotherapy. Prior murine studies suggest that alternate-day fasting may attenuate doxorubicin cardiotoxicity and stimulate nuclear translocation of transcription factor EB (TFEB), a master regulator of autophagy and lysosomal biogenesis. In this study, human heart tissue from patients with doxorubicin-induced heart failure demonstrated increased nuclear TFEB protein. In mice treated with doxorubicin, alternate-day fasting or viral TFEB transduction increased mortality and impaired cardiac function. Mice randomized to alternate-day fasting plus doxorubicin exhibited increased TFEB nuclear translocation in the myocardium. When combined with doxorubicin, cardiomyocyte-specific TFEB overexpression provoked cardiac remodeling, while systemic TFEB overexpression increased growth differentiation factor 15 (GDF15) and caused heart failure and death. Cardiomyocyte TFEB knockout attenuated doxorubicin cardiotoxicity, while recombinant GDF15 was sufficient to cause cardiac atrophy. Our studies identify that both sustained alternate-day fasting and a TFEB/GDF15 pathway exacerbate doxorubicin cardiotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Washington University School of Medicine, St. Louis, MO 63110, USA.
- Beth Israel and Harvard Medical School, Boston, MA, USA.
- St. Luke's Kansas City, Kansas City, MO, USA.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Washington University School of Medicine, St. Louis, MO 63110, USA; John Cochran Veterans Affairs Medical Center, Saint Louis, MO, USA.
- Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: ali.javaheri@wustl.edu.
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- BLRD VA
- NINDS NIH HHS
- NIH HHS
- Washington University in Saint Louis Children's Discovery Institute
- NHLBI
- NIH
Zitieren
APA
Ozcan, M., Guo, Z., Valenzuela Ripoll, C., Diab, A., Picataggi, A., Rawnsley, D., Lotfinaghsh, A., Bergom, C., Szymanski, J., Hwang, D., Asnani, A., Kosiborod, M., Zheng, J., Hayashi, R. J., Woodard, P. K., Kovacs, A., Margulies, K. B., Schilling, J., Razani, B., …, & Javaheri, A. (2023). Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity. Cell Metabolism. https://doi.org/10.1016/j.cmet.2023.02.006
Vancouver
Ozcan M, Guo Z, Valenzuela Ripoll C, Diab A, Picataggi A, Rawnsley D, et al. Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity. Cell Metabolism. 2023. doi:10.1016/j.cmet.2023.02.006
BibTeX
@article{Ozcan2023,
author = {Ozcan, Mualla and Guo, Zhen and Valenzuela Ripoll, Carla and Diab, Ahmed and Picataggi, Antonino and Rawnsley, David and Lotfinaghsh, Aynaz and Bergom, Carmen and Szymanski, Jeff and Hwang, Daniel and Asnani, Aarti and Kosiborod, Mikhail and Zheng, Jie and Hayashi, Robert J and Woodard, Pamela K and Kovacs, Attila and Margulies, Kenneth B and Schilling, Joel and Razani, Babak and Diwan, Abhinav and Javaheri, Ali},
title = {Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity},
journal = {Cell Metabolism},
year = {2023},
doi = {10.1016/j.cmet.2023.02.006}
}
EUVIMED